← Dashboard
Nov 06, 2026 11:48 PM ET
Signal
Corporate
bioAffinity Technologies GAAP EPS of -$5.89, revenue of $1.1M
bioAffinity Technologies GAAP EPS of -$5.89, revenue of $1.1M
What changed
bioAffinity Technologies GAAP EPS of -$5.89, revenue of $1.1M
Why it matters
bioAffinity Technologies GAAP EPS of -$5.89, revenue of $1.1M — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →
FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →
$FMX →